Fig. 1From: Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkersFigure created with Biorender.comTypical workflow for the analysis of protein cancer biomarkers from liquid biopsies via targeted mass spectrometry. SIS stable isotope labeled standard, LC liquid chromatography, MS/MS tandem mass spectrometry, ESI electrospray ionization.Back to article page